SHUKRAPHAR vs M&MFIN: Stock Comparison
Head-to-head financial and trading comparison between Shukra Pharmaceuticals Limited (SHUKRAPHAR) and Mahindra & Mahindra Financial Services Limited (M&MFIN) in the Cross-Sector Peers sector.
SHUKRAPHAR
NSE: SHUKRAPHARM&MFIN
NSE: M&MFINKey Metrics Comparison Table
| Metric | SHUKRAPHAR | M&MFIN | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹66.94 | ₹319.45 | — |
| 1-Year Price Return | +61.61% | +5.22% | SHUKRAPHAR (56.39% higher) |
| 52-Week High | ₹72.58 | ₹412.30 | — |
| 52-Week Low | ₹41.42 | ₹275.70 | — |
| 30-Day Annualized Volatility | 64.68% | 26.44% | M&MFIN (Steadier) |
| 30-Day Average Daily Volume | 6,592,919 | 1,848,112 | SHUKRAPHAR (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SHUKRAPHAR and M&MFIN, which stock gave better returns over the last year?
SHUKRAPHAR has outperformed M&MFIN over the past 12 months with a gain of 61.61% compared to 5.22%.
Which stock is less volatile: SHUKRAPHAR or M&MFIN?
M&MFIN demonstrated lower price volatility (26.44% annualized) compared to SHUKRAPHAR (64.68%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SHUKRAPHAR vs M&MFIN?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SHUKRAPHAR and M&MFIN direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.